Eurofins Scientific SE/ FR0014000MR3 /
| 31.05.2024 16:52:17 | Diff. +0,08 | Volumen | Geld17:30:00 | Brief17:22:18 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 55,51EUR | +0,14% | 727 Umsatz: 40.310,14 |
-Geld Vol: - | -Brief Vol: - | 10,68 Mrd.EUR | 0,90% | 18,70 |
Aktiva
|
2019 IFRS in Mio. EUR |
2020 IFRS in Mio. EUR |
2021 IFRS in Mio. EUR |
2022 IFRS in Mio. EUR |
2023 IFRS in Mio. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 1.593,5000 | 1.574,9000 | 1.829,9000 | 2.167,7000 | 2.297,4000 | ||||||
| Immaterielle Vermögensgegenstände | 918,2000 | 825,1000 | 895,7000 | 919,1000 | 796 | ||||||
| Finanzanlagen | 49,2000 | 51 | 81,7000 | 83,6000 | 83,6000 | ||||||
| Anlagevermögen | - | - | 7.013,3000 | 7.770,2000 | 7.822,2000 | ||||||
| Vorräte | 79,3000 | 157 | 154,2000 | 145,6000 | 139 | ||||||
| Forderungen | 1.001,2000 | 948,5000 | 1.051,8000 | 1.053,3000 | 1.072,8000 | ||||||
| Liquide Mitteln | 297 | 912,4000 | 515,3000 | 486,6000 | 1.221,2000 | ||||||
| Umlaufvermögen | 1.604,1000 | 2.518,2000 | 2.319 | 2.313,3000 | 3.066,4000 | ||||||
| Aktiva, gesamt | 7.823,1000 | 8.575,5000 | 9.332,3000 | 10.083,5000 | 10.888,6000 | ||||||
Passiva
|
2019 IFRS in Mio. EUR |
2020 IFRS in Mio. EUR |
2021 IFRS in Mio. EUR |
2022 IFRS in Mio. EUR |
2023 IFRS in Mio. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 409,8000 | 542 | 627,6000 | 647,7000 | 600,2000 | ||||||
| Langfristige Schulden | - | - | 2.500,3000 | 3.111,8000 | 3.325,6000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | 504,8000 | 288,9000 | - | - | - | ||||||
| Rückstellungen | 124,5000 | 115,3000 | 168,5000 | 187,3000 | 152,3000 | ||||||
| Verbindlichkeiten | 4.925 | 4.859,1000 | 4.655,1000 | 5.232,5000 | 5.751,2000 | ||||||
| Gezeichnetes Kapital | 1,8000 | 1,9000 | - | - | - | ||||||
| Eigenkapital | 2.838,6000 | 3.690,3000 | 4.647,6000 | 4.782,1000 | 5.077,5000 | ||||||
| Minderheitenanteile | 59,5000 | 26,1000 | 29,5000 | 68,9000 | 59,9000 | ||||||
| Passiva, gesamt | 7.823,1000 | 8.575,5000 | 9.332,3000 | 10.083,5000 | 10.888,6000 | ||||||
Gewinn- und Verlustrechnung
|
2019 IFRS in Mio. EUR |
2020 IFRS in Mio. EUR |
2021 IFRS in Mio. EUR |
2022 IFRS in Mio. EUR |
2023 IFRS in Mio. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 4.562,8000 | 5.438,8000 | 6.717,7000 | 6.712,1000 | 6.514,6000 | ||||||
| Abschreibungen (Gesamt) | 395,9000 | 426 | 450,7000 | 476 | 522 | ||||||
| Betriebsergebnis | 366,6000 | 800,3000 | 1.258,2000 | 1.036,9000 | 841,7000 | ||||||
| Zinsergebnis | -95,7000 | -107,7000 | -203,7000 | -134,1000 | -106 | ||||||
| Ergebnis vor Steuern | 271,5000 | 694,4000 | 1.056,6000 | 903,7000 | 736,1000 | ||||||
| Ertragsteuern | 76,3000 | 153,9000 | 273,6000 | 220,7000 | 168,4000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | 0.0000 | 0.0000 | ,4000 | 4,4000 | -2,4000 | ||||||
| Konzernjahresüberschuss | 195,2000 | 540,5000 | 782,6000 | 687,4000 | 570,2000 | ||||||
Pro Aktie
Cash Flow
|
2019 IFRS in Mio. EUR |
2020 IFRS in Mio. EUR |
2021 IFRS in Mio. EUR |
2022 IFRS in Mio. EUR |
2023 IFRS in Mio. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 677,9000 | 1.223,5000 | 1.511,4000 | 1.136,3000 | 1.017,9000 | ||||||
| Cash Flow aus Investitionstätigkeit | -540,2000 | -525 | -1.021 | -855,9000 | -681,1000 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -342,2000 | -48,6000 | -910,3000 | -311,3000 | 413,6000 | ||||||
| Veränderung der liquiden Mittel | -200,5000 | 616 | - | - | - | ||||||
| Anzahl der Mitarbeiter | 43.320 | 51.516 | 57.992 | 61.379 | 61.798 | ||||||
